Holen Sie sich die Stockscreener-App
25.18
0.18%
-0.045
Schlusskurs vom Vortag:
$25.23
Offen:
$25.18
24-Stunden-Volumen:
1,064
Relative Volume:
0.11
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.10%
1M Leistung:
-0.22%
6M Leistung:
-0.92%
1J Leistung:
+0.00%
1-Tages-Spanne:
$25.18
$25.18
1-Wochen-Bereich:
$25.16
$25.23
52-Wochen-Spanne:
$24.96
$25.54
Shl Telemedicine Ltd Performanc Stock (STBF) Company Profile
Firmenname
Shl Telemedicine Ltd Performanc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie STBF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STBF
Shl Telemedicine Ltd Performanc
|
25.18 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
295.12 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
599.14 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
602.00 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
232.89 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
529.92 | 124.43B | 0 | 0 | 0 | 0.00 |
Shl Telemedicine Ltd Performanc Aktie (STBF) Neueste Nachrichten
Take Care Before Jumping Onto SHL Telemedicine Ltd. (VTX:SHLTN) Even Though It's 26% Cheaper - Simply Wall St
DocGo and SHL Telemedicine Partner to Revolutionize Patient Access to Cardiovascular Care - Business Wire
SHL Telemedicine (NASDAQ:SHLT) Shares Up 23.7%What's Next? - MarketBeat
Y.D. More Investments Ltd Reduces Stake in SHL Telemedicine Ltd - GuruFocus.com
SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine - Business Wire
SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity - Business Wire
SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test - Business Wire
SHL Telemedicine Announces Official Launch of SmartHeart - Business Wire
SHL Announces Full-Year 2023 ResultsStable Revenue Growth Alongside Groundbreaking Clinical Milestones - Business Wire
Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care - Business Wire
SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment - Business Wire
SHL Telemedicine: Invitation to Conference Call Presenting Annual Results 2023 - Business Wire
SHL Telemedicine Receives Buy Rating with $11.00 Price Target - Business Wire
Imperial College London TELE-ACS Clinical Trial Results, Using SHL Telemedicine’s SmartHeart® Technology, to Be Presented at ACC 24 - Business Wire
SHL Telemedicine Introduces SmartHeart® Direct-to-Consumer Membership Plan in the US - Business Wire
SHL Telemedicine Establishes US Nationwide Cardiology Network for ECG Interpretations and Telehealth Visits - Business Wire
SHL Telemedicine Announces Advancements in its Direct-to-Consumer Strategy in the US - Business Wire
SHL Announces Half-Year Results 2023 – Strategic Moves to Accelerate Growth - Business Wire
SHL Telemedicine to Commence Trading on NASDAQ Under the Symbol "SHLT" - PR Newswire
Finanzdaten der Shl Telemedicine Ltd Performanc-Aktie (STBF)
Es liegen keine Finanzdaten für Shl Telemedicine Ltd Performanc (STBF) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.99%
Kapitalisierung:
|
Volumen (24h):